DIVERGIMAB
associated with 1 other trademarks
Scientific research services for others in the field of genetics and monoclonal antibodies; Research and development services in the field of monoclon...

Words that describe this trademark:

research platform  genetic research  antibodies  therapeutics  therapeutic  generation  discovery  platform  reagent 

Serial Number:

90826231

Mark:

DIVERGIMAB

Status:

Registered

Status Date:

03-05-2024

Filing Date:

Registration Number:

7323273

Registration Date:

03-05-2024

Goods and Services:

Scientific research services for others in the field of genetics and monoclonal antibodies; Research and development services in the field of monoclonal antibodies, namely, development of antibody-based therapeutics and discovery of reagents; Research and development services in the field of monoclonal antibodies, namely, generation of therapeutic and reagent antibodies; Genetic engineering services, namely, the production of genetically-engineered mice and monoclonal antibodies for others

Mark Description:

N/A

Class:

Scientific and technological services

Type of Mark:

Servicemark

Published for Opposition Date:

07-19-2022

Mark Drawing Status:

Standart Character Mark

Abandon Date:

N/A

Business Name:

NUTTER, MCCLENNEN & FISH, LLP

Correspondent Name:

Recent Trademark filings by this company